Literature DB >> 22925619

Difficulties with assessing the benefit of glucosamine sulphate as a treatment for osteoarthritis.

Nikki Burdett1, Julian David McNeil.   

Abstract

Osteoarthritis is a chronic disease with a major impact on quality of life for a large proportion of the population. It is a disease for which to date there has been no disease-modifying therapy identified. As a result of its physiological role in articular cartilage, glucosamine sulphate has been postulated as a treatment for osteoarthritis. Claims have included symptomatic relief and even reduction in the rate of disease progression. Despite promising in vitro studies, however, the role of glucosamine sulphate in the management of osteoarthritis remains unclear. Studies addressing this issue have generated a wide range of conclusions, and these are discussed here. Methodological issues need to be addressed in order to gauge whether there is true benefit. On current evidence, it would appear that the benefits of dietary supplementation with glucosamine sulphate are limited to mild symptomatic relief, while a disease-modifying agent for this disease remains elusive.
© 2012 The Authors. International Journal of Evidence-Based Healthcare © 2012 The Joanna Briggs Institute.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22925619     DOI: 10.1111/j.1744-1609.2012.00279.x

Source DB:  PubMed          Journal:  Int J Evid Based Healthc        ISSN: 1744-1595


  2 in total

1.  In Vivo Osteoinduction: Evaluating 2-Beta Coxatene as an Immunoinductive Compound and Novel Ingredient for Joint Support.

Authors:  Katherine Spinks; James J Scaffidi
Journal:  Integr Med (Encinitas)       Date:  2016-10

Review 2.  Developing criteria for evaluation of geroprotectors as a key stage toward translation to the clinic.

Authors:  Alexey Moskalev; Elizaveta Chernyagina; Vasily Tsvetkov; Alexander Fedintsev; Mikhail Shaposhnikov; Vyacheslav Krut'ko; Alex Zhavoronkov; Brian K Kennedy
Journal:  Aging Cell       Date:  2016-03-11       Impact factor: 9.304

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.